AravindhanVeerapandiyanMD

Pediatrics • Little Rock, AR

Child Neurology

Physician

Join to view full profile

Dr. Veerapandiyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Veerapandiyan's full profile

Already have an account?

Office
1 Children's Way
Arkansas Children’s Hospital
Little Rock, AR 72202
Phone+1 501-364-1100

Fax+1 501-364-4777

Summary

Dr. Aravindhan Veerapandiyan is a pediatrician in Little Rock, AR and is affiliated with multiple hospitals in the area, including Arkansas Children's Hospital and UAMS Medical Center. He received his medical degree from Other and has been in practice 12 years. He specializes in child neurology and is experienced in spinal muscular atrophy, duchenne muscular dystrophy, myotonic disorders, charcot-marie-tooth disease, and pediatric neuromuscular medicine.

Education & Training

University of RochesterFellowship, Neuromuscular Medicine (Neurology), 2018
Rutgers Health/New Jersey Medical SchoolResidency, Child Neurology, 2014 - 2017
OtherClass of 2007

Certifications & Licensure

AR State Medical License 2017 - 2025
PA State Medical License 2017 - 2018
NJ State Medical License 2013 - 2017
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy Start of enrollment: 2021 Mar 03
Completed
Phase 2, Phase 3
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice Start of enrollment: 2021 Apr 22
Recruiting
CureDuchenne Link®: A Resource for Research Start of enrollment: 2021 Jul 09
Recruiting
Roles: Contact
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2023 May 31
Recruiting
Phase 3
Roles: Principal Investigator
An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy Start of enrollment: 2024 Feb 07
Recruiting
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2023 Jan 04
Recruiting
Phase 1, Phase 2
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) Start of enrollment: 2023 May 31
Recruiting
Phase 3
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Start of enrollment: 2022 Jun 22
Recruiting
Phase 3
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy Start of enrollment: 2021 Aug 23
Recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy.
Olivia Baldi, Kathi Kinnett, Rachel Schrader, Brian Denger, Natalie Truba
Muscle & Nerve. 2025-03-01
1 citations
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.
Mary K Schroth, Jennifer Deans, Diana X Bharucha Goebel, W Bryan Burnette, Basil T Darras
Neurology. Clinical Practice. 2025-02-01
1 citations
The BELS questionnaire: A novel screening tool for neurodevelopmental and psychiatric symptoms in pediatric dystrophinopathy.
Natalie Truba, Seth Sorensen, Rachel Bearden, Brett Haley, Beverly Spray
Muscle & Nerve. 2025-02-01

Press Mentions

Health Insurers Deny 850 Million Claims a Year. The Few Who Appeal Often Win.February 13th, 2025
Revolutionary Gene Therapies Offer New Hope for Boys with Duchenne Muscular DystrophyDecember 20th, 2024
REGENXBIO Gene Therapy Advances to Pivotal Trials in DMDNovember 20th, 2024
Join now to see all

AravindhanVeerapandiyanMD

Dr. Veerapandiyan is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.